Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tozuleristide and Canvas System in Adult Primary CNS Tumors
NCT04743310Phase 2Completed
- Sponsor
- Kairos Pharma Ltd.
- Start
- Sep 2021
- Primary completion
- Mar 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of tozuleristide in central nervous system tumor, sponsored by Kairos Pharma Ltd.. Started Sep 2021; status: completed.
02
Drugs
tozuleristide
03
Conditions
central nervous system tumor
Beyond the preview
Go deeper on NCT04743310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04743310.